通过互联网为本科女性提供性侵犯抵抗干预 (IDEA3试验):多站点随机控制有效性试验的协议
Sarah M Peitzmeier1, Charlene Y Senn2, Misha Eliasziw3
1Department of Behavioral and Community Health, School of Public Health, University of Maryland, College Park, College Park, MD, United States.
JMIR research protocols
|October 7, 2025
概括
本研究测试了基于互联网的EAAA (IDEA3),这是一个基于网络的程序,旨在减少本科生女性的性侵犯 (SA). 早期结果尚未公布,但该计划旨在为校园安全提供可扩展的解决方案.
科学领域:
- 公共卫生 公共卫生
- 心理学 心理学 心理学
- 在线干预在线干预
背景情况:
- 性侵犯 (SA) 是大学校园的一个重要问题,估计会影响五分之一的女学生.
- 现有的预防计划需要适应更广泛的可访问性和有效性.
研究的目的:
- 评估互联网交付EAAA (IDEA3) 计划在减少本科生女性强奸事件发生率方面的有效性.
- 评估IDEA3对其他形式的性侵犯,幸存者自责以及相关心理因素的影响.
- 探索该计划对接受性侵略和性赋权的影响.
主要方法:
- 一个多站点的,开放标签的随机受控试验,涉及1920名加拿大和美国大学的不同女性学生.
- 参与者被随机分配,接受12小时的IDEA3干预或60分钟的标准在线同意研讨会.
- 结果,包括SA发生率,自我责怪和调解者,在基线,干预后1周,6个月和12个月使用性经验调查简单表格进行了测量.
主要成果:
- 招聘于2023年10月启动,截至2025年8月,683名参与者被录取并随机选择.
- 数据收集正在进行中,预计将于2027年5月结束.
- 目前还没有有效性数据,因为该研究处于积极数据收集阶段.
结论:
- IDEA3计划有可能为高等教育中预防性侵犯提供基于证据的,具有成本效益的,可扩展的解决方案.
- 成功实施可能会在国际上对妇女的健康和安全产生重大影响,并与SA预防计划的任务保持一致.
- 该研究的结果将指导IDEA3在加拿大和美国大学的更广泛传播.
关键词:
教育教育教育教育的教育.干预干预干预干预干预干预电阻的电阻是指电阻的电阻性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯性侵犯大学的大学.女人 女人 女人 女人 女人
相关概念视频
01:13Randomized Experiments
8.8K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
8.8K
02:01Group Design
10.1K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
10.1K
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
170
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
170
01:11Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
01:11Blinding
3.8K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.8K